by admin | Jul 30, 2020 | news
Tensions between the White House and Big Pharma have ratcheted up after President Donald Trump announced four executive orders targeting the pharmaceutical industry. On Tuesday morning, the president fired off the latest public salvo, while Pfizer CEO Albert Bourla...
by Viara Staneva | Jul 30, 2020 | news
Bob Nelsen had been quietly wondering how to eradicate viruses for years, before one day in 2015, he welcomed a pair of immunologists into the ARCH Venture Partners offices on the 34th floor of Seattle’s Wells Fargo Building. Louis Picker and Klaus Früh, professors at...
by admin | Jun 19, 2020 | news
John Young, Pfizer’s chief business officer, was only about four minutes into a one-hour fireside chat at this year’s virtual BIO conference when he addressed a question that’s been weighing on investors for several weeks now: If the company successfully develops a...
by admin | Jun 15, 2020 | news
An annual survey of pharma sales rep salaries showed another year-over-year increase, but it also revealed concerns about the impact of the COVID-19 pandemic. Salaries averaged more than $150,000 in 2019, for an increase of 6%. However, three-fourths of the pharma...
by admin | May 4, 2020 | news
A new study out of China has tied T cell activation to Roche’s IL-6 inhibitor Actemra, which has shown some early effect in treating cytokine storm in severe COVID-19 patients. Meanwhile, the National Institutes of Health has kicked off a “Shark...
by admin | May 2, 2020 | news
COVID-19 is making the case for accelerating the move to more value-based models of care. Hospitals’ financial struggles as they pause elective procedures during the pandemic highlight the weaknesses in a volume-based system, said Craig Samitt, M.D., CEO of...
